ACE and chronic kidney disease: In a previous retrospective cohort study, angiotensin-converting enzyme inhibitors were associated with lower incidence rates of liver cancer and cirrhosis in patients with CKD (CKD-weighted subdistribution HR: 0.15, 95% CI: 0.07–0.33, p < 0.001) [24].